Your browser doesn't support javascript.
loading
Multiple alterations in glutamatergic transmission and dopamine D2 receptor splicing in induced pluripotent stem cell-derived neurons from patients with familial schizophrenia.
Yamamoto, Kana; Kuriu, Toshihiko; Matsumura, Kensuke; Nagayasu, Kazuki; Tsurusaki, Yoshinori; Miyake, Noriko; Yamamori, Hidenaga; Yasuda, Yuka; Fujimoto, Michiko; Fujiwara, Mikiya; Baba, Masayuki; Kitagawa, Kohei; Takemoto, Tomoya; Gotoda-Nishimura, Nanaka; Takada, Tomohiro; Seiriki, Kaoru; Hayata-Takano, Atsuko; Kasai, Atsushi; Ago, Yukio; Kida, Satoshi; Takuma, Kazuhiro; Ono, Fumihito; Matsumoto, Naomichi; Hashimoto, Ryota; Hashimoto, Hitoshi; Nakazawa, Takanobu.
Affiliation
  • Yamamoto K; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, 565-0871, Japan.
  • Kuriu T; Osaka Medical and Pharmaceutical University, Research and Development Center, Osaka, 569-8686, Japan.
  • Matsumura K; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, 565-0871, Japan.
  • Nagayasu K; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, 565-0871, Japan.
  • Tsurusaki Y; Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, 606-8501, Japan.
  • Miyake N; Department of Human Genetics, Yokohama City University Graduate School of Medicine, Kanagawa, 236-0004, Japan.
  • Yamamori H; Faculty of Nutritional Science, Sagami Women's University, Kanagawa, 252-0383, Japan.
  • Yasuda Y; Department of Human Genetics, Yokohama City University Graduate School of Medicine, Kanagawa, 236-0004, Japan.
  • Fujimoto M; Department of Human Genetics, Research Institute, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan.
  • Fujiwara M; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, 187-8553, Japan.
  • Baba M; Department of Psychiatry, Graduate School of Medicine, Osaka University, Osaka, 565-0871, Japan.
  • Kitagawa K; Japan Community Health Care Organization Osaka Hospital, Osaka, 553-0003, Japan.
  • Takemoto T; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, 187-8553, Japan.
  • Gotoda-Nishimura N; Medical Corporation Foster, Osaka, 531-0075, Japan.
  • Takada T; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, 187-8553, Japan.
  • Seiriki K; Department of Psychiatry, Graduate School of Medicine, Osaka University, Osaka, 565-0871, Japan.
  • Hayata-Takano A; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, 565-0871, Japan.
  • Kasai A; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, 565-0871, Japan.
  • Ago Y; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, 565-0871, Japan.
  • Kida S; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, 565-0871, Japan.
  • Takuma K; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, 565-0871, Japan.
  • Ono F; Laboratory of Molecular Biology, Department of Bioscience, Graduate School of Life Sciences, Tokyo University of Agriculture, Tokyo, 156-8502, Japan.
  • Matsumoto N; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, 565-0871, Japan.
  • Hashimoto R; Interdisciplinary Program for Biomedical Sciences, Institute for Transdisciplinary Graduate Degree Programs, Osaka University, Osaka, 565-0871, Japan.
  • Hashimoto H; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, 565-0871, Japan.
  • Nakazawa T; Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University, and University of Fukui, Osaka, 565-0871, Japan.
Transl Psychiatry ; 11(1): 548, 2021 10 25.
Article in En | MEDLINE | ID: mdl-34697299
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Induced Pluripotent Stem Cells Type of study: Prognostic_studies Limits: Humans Language: En Journal: Transl Psychiatry Year: 2021 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Induced Pluripotent Stem Cells Type of study: Prognostic_studies Limits: Humans Language: En Journal: Transl Psychiatry Year: 2021 Document type: Article